188 related articles for article (PubMed ID: 22475925)
1. Squamous papilloma of the oral cavity and oropharynx on 18F-FDG PET/CT imaging.
Karantanis D; Allen-Auerbach M; Czernin J
Clin Nucl Med; 2012 May; 37(5):e98-9. PubMed ID: 22475925
[TBL] [Abstract][Full Text] [Related]
2. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
Krabbe CA; Balink H; Roodenburg JL; Dol J; de Visscher JG
Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1263-70. PubMed ID: 21824748
[TBL] [Abstract][Full Text] [Related]
3. Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
Hong HR; Jin S; Koo HJ; Roh JL; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2014 Nov; 110(6):696-701. PubMed ID: 24995957
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
5. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT.
Lim S; Lee EH; Park JM; Chang YW; Kim HH; Jeong SH
Acta Radiol; 2013 Dec; 54(10):1117-24. PubMed ID: 23864064
[TBL] [Abstract][Full Text] [Related]
6. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
[TBL] [Abstract][Full Text] [Related]
7. Assessment of a new 18F-FDG PET/CT protocol in the staging of oral cavity carcinomas.
Cistaro A; Palandri S; Balsamo V; Migliaretti G; Pentenero M; Testa C; Cusmà S; Ceraudo F; Gandolfo S; Ficola U
J Nucl Med Technol; 2011 Mar; 39(1):7-13. PubMed ID: 21321252
[TBL] [Abstract][Full Text] [Related]
8. Variety and complexity of fluorine-18-labelled fluoro-2-deoxy-D-glucose accumulations in the oral cavity of patients with oral cancers.
Kito S; Koga H; Kodama M; Habu M; Kokuryo S; Yamamoto N; Oda M; Nishino T; Zhang M; Matsuo K; Wakasugi-Sato N; Matsumoto-Takeda S; Seta Y; Yoshiga D; Kaneuji T; Nogami S; Yoshioka I; Yamashita Y; Tanaka T; Miyamoto I; Kitamura C; Tominaga K; Morimoto Y
Dentomaxillofac Radiol; 2013; 42(7):20130014. PubMed ID: 23610089
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.
Pasha MA; Marcus C; Fakhry C; Kang H; Kiess AP; Subramaniam RM
AJR Am J Roentgenol; 2015 Aug; 205(2):W150-61. PubMed ID: 26001119
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT findings in patients with Kikuchi disease.
Kong E; Chun K; Hong Y; Hah J; Cho I
Nuklearmedizin; 2013; 52(3):101-6. PubMed ID: 23681151
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET evaluation of sinonasal papilloma.
Cohen EG; Baredes S; Zuckier LS; Mirani NM; Liu Y; Ghesani NV
AJR Am J Roentgenol; 2009 Jul; 193(1):214-7. PubMed ID: 19542416
[TBL] [Abstract][Full Text] [Related]
12. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C
Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
[TBL] [Abstract][Full Text] [Related]
13. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
14. A Case of Oral Metastasis From Hepatocellular Carcinoma Displayed on 18F-FDG PET/CT Imaging.
Jiang L; Gu T; Liu F; Luan L; Shi H
Clin Nucl Med; 2016 Jan; 41(1):72-3. PubMed ID: 26359556
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the intratumoral heterogeneity of (18) F-FDG uptake in oral cavity cancer.
Kwon SH; Yoon JK; An YS; Shin YS; Kim CH; Lee DH; Jo KS; Lee SJ
J Surg Oncol; 2014 Nov; 110(6):702-6. PubMed ID: 24975131
[TBL] [Abstract][Full Text] [Related]
16. Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
Kim M; Achmad A; Higuchi T; Arisaka Y; Yokoo H; Yokoo S; Tsushima Y
J Nucl Med; 2015 Jan; 56(1):16-21. PubMed ID: 25476535
[TBL] [Abstract][Full Text] [Related]
17. Detection of cervical metastases with (11)C-tyrosine PET in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with (18)F-FDG PET.
Krabbe CA; van der Werff-Regelink G; Pruim J; van der Wal JE; Roodenburg JL
Head Neck; 2010 Mar; 32(3):368-74. PubMed ID: 19626632
[TBL] [Abstract][Full Text] [Related]
18. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY
Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and incremental benefit of puffed-cheek 18F-FDG PET/CT on oral cancer patients.
Chang CY; Yang BH; Lin KH; Liu RS; Wang SJ; Shih WJ
Clin Nucl Med; 2013 Oct; 38(10):e374-8. PubMed ID: 23989442
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
Piao Y; Bold B; Tayier A; Ishida R; Omura K; Okada N; Shibuya H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):933-8. PubMed ID: 19846326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
